中国学者近期发表的论文
1.	Prospects of immunotherapy for cancer Author: Zhinan Chen Journal: Frontiers of Medicine, 2019, Vol.13, 1-2, DOI:10.1007/s11684-019-0691-y    DOI
2.	New incompatible pair of TCM: Epimedii Folium combined with Psoraleae Fructus induces idiosyncratic hepatotoxicity under immunological stress conditions Author: Yuan Gao, Zhilei Wang, Jinfa Tang, Xiaoyi Liu, Wei Shi, Nan Qin, Xiaoyan Wang, Yu Pang, Ruisheng Li, Yaming Zhang, Jiabo Wang, Ming Niu, Zhaofang Bai, Xiaohe Xiao Journal: Frontiers of Medicine, 2019, Vol., , DOI:10.1007/s11684-019-0690-z    DOI
3.	Urotensin II receptor antagonist reduces hepatic resistance and portal pressure through enhanced eNOS-dependent HSC vasodilatation in CCl<Subscript>4</Subscript>-induced cirrhotic rats Author: Ruoxi Zhang, Jing Chen, Diangang Liu, Yu Wang Journal: Frontiers of Medicine, 2019, Vol., , DOI:10.1007/s11684-019-0689-5    DOI
4.	Immunotherapy-based combination strategies for treatment of gastrointestinal cancers: current status and future prospects Author: Chenfei Zhou, Jun Zhang Journal: Frontiers of Medicine, 2019, Vol.13, 12-23, DOI:10.1007/s11684-019-0685-9    DOI
5.	Chimeric antigen receptor T cell targeting EGFRvIII for metastatic lung cancer therapy Author: Zhao Zhang, Jun Jiang, Xiaodong Wu, Mengyao Zhang, Dan Luo, Renyu Zhang, Shiyou Li, Youwen He, Huijie Bian, Zhinan Chen Journal: Frontiers of Medicine, 2019, Vol.13, 57-68, DOI:10.1007/s11684-019-0683-y    DOI
6.	Growth suppression of colorectal cancer expressing S492R EGFR by monoclonal antibody CH12 Author: Qiongna Dong, Bizhi Shi, Min Zhou, Huiping Gao, Xiaoying Luo, Zonghai Li, Hua Jiang Journal: Frontiers of Medicine, 2019, Vol.13, 83-93, DOI:10.1007/s11684-019-0682-z    DOI
7.	Presence of multiple abnormal immunologic markers is an independent prognostic factor of diffuse large B-cell lymphoma Author: Yiwen Cao, Zhenhua Liu, Wen Wu, Ying Qian, Qin Shi, Rong Shen, Binshen Ouyang, Pengpeng Xu, Shu Cheng, Jin Ye, Yiming Lu, Chaofu Wang, Chengde Yang, Li Wang, Weili Zhao Journal: Frontiers of Medicine, 2019, Vol.13, 94-103, DOI:10.1007/s11684-019-0680-1    DOI
8.	Monitoring checkpoint inhibitors: predictive biomarkers in immunotherapy Author: Min Zhang, Jingwen Yang, Wenjing Hua, Zhong Li, Zenghui Xu, Qijun Qian Journal: Frontiers of Medicine, 2019, Vol.13, 32-44, DOI:10.1007/s11684-018-0678-0    DOI
9.	High-affinity T cell receptors redirect cytokine-activated T cells (CAT) to kill cancer cells Author: Synat Kang, Yanyan Li, Yifeng Bao, Yi Li Journal: Frontiers of Medicine, 2019, Vol.13, 69-82, DOI:10.1007/s11684-018-0677-1    DOI
10.	PD-1/PD-L1 blockade in cervical cancer: current studies and perspectives Author: Yumeng Wang, Guiling Li Journal: Frontiers of Medicine, 2019, Vol., , DOI:10.1007/s11684-018-0674-4    DOI

同类著名期刊名称 h-index CiteScore Science Translational Medicine 168 8.28 Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology 0 0.00 Stem Cell Research & Therapy 56 4.83 JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 108 4.48 EXPERT REVIEWS IN MOLECULAR MEDICINE 73 4.31 Human Gene Therapy Clinical Development 16 1.85 American Journal of Translational Research 45 3.30 Journal of Cardiovascular Translational Research 44 2.09 Journal of Diabetes Research 33 3.02 JOURNAL OF INVESTIGATIVE MEDICINE 59 1.82

中科院JCR同大类学科的热搜期刊 浏览次数 MEDICINE 299635 CANCER RESEARCH 165726 Molecular Medicine Reports 164511 International Journal of Nanomedicine 164278 CANCER LETTERS 159326 JOURNAL OF ETHNOPHARMACOLOGY 141491 BIOMEDICINE & PHARMACOTHERAPY 140356 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 135813 Theranostics 135753 International Journal of Environmental Research and Public Health 133446